Login / Signup
Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis.
Jaejun Lee
Ahlim Lee
Pil Soo Sung
Jeong Won Jang
Si Hyun Bae
Jong Young Choi
Seung Kew Yoon
Hyun Yang
Published in:
The Korean journal of internal medicine (2024)
Four high-genetic barrier NAs were compared, and TDF was more likely to achieve a VR after 48 weeks, while ETV provided a superior BR after 48 weeks.
Keyphrases
</>
end stage renal disease
ejection fraction
genome wide
chronic kidney disease
newly diagnosed
acute lymphoblastic leukemia
peritoneal dialysis
hepatitis b virus
copy number
prognostic factors
gene expression
gestational age
molecular docking
dna methylation
liver fibrosis
replacement therapy